USFDA Approved Biosimilars


The European regulatory authorities led with a specially adapted approval procedure to authorize subsequent versions of previously approved Biologics, termed "similar biological medicinal products", or Biosimilars. This procedure is based on a thorough demonstration of "comparability" of the "similar" product to an existing approved product. In the United States, the Food and Drug Administration (FDA) held that new legislation was required to enable them to approve Biosimilars to those Biologics originally approved through the PHS Act pathway. The FDA gained the authority to approve Biosimilars (including interchangeable that are substitutable with their reference product) as part of the Patient Protection and Affordable Care Act signed by President Obama on March 23, 2010.


    Related Conference of USFDA Approved Biosimilars

    July 21-22, 2025

    11th International Conference on Antimicrobials & Antibiotic Resistance

    Vancouver, Canada
    July 21-22, 2025

    28th World Congress on Nursing, Pharmacology and Healthcare

    Barcelona, Spain
    July 24-25, 2025

    5th World Congress on Cardiovascular Medicine Pharmacology

    Paris, France
    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    August 21-22, 2025

    5th International Conference on Pharmaceutical Chemistry

    Dublin, Ireland
    August 25-26, 2025

    11th International Conference on Pharmaceutical Regulatory Affairs and IPR

    Vancouver, Canada
    September 08-09, 2025

    26th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems

    Frankfurt, Germany
    September 08-09, 2025

    13th International Conference and Exhibition on Natural Products and Medicinal Plants Research

    Frankfurt, Germany
    September 15-16, 2025

    42nd International Conference on Drug Discovery and Drug delivery system

    Paris, France
    September 19-20, 2025

    18th World Drug Delivery Summit

    Paris, France
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 22-23, 2025

    20th International Conference on Pharmaceutical Formulations & Drug Delivery

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    October 16-17, 2025

    18th International Conference on Pharmaceutics and Drug Safety

    Berlin,
    October 22-23, 2025

    7th European Conference on Advance Clinical Trials and Research

    Paris, France
    November 13-14, 2025

    28th International Conference and Exhibition on Pharmaceutical Formulations

    Paris, France
    November 13-14, 2025

    21st International Conference on Pharmaceutical Chemistry

    Aix-en-Provence, France
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Paris, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 27-28, 2025

    13th International Conference on Clinical Trials

    Amsterdam, Netherlands
    January 28-29, 2026

    23rd International Pharmaceutical Sciences & Life Saving Drugs

    Bangkok, Thailand
    February 23-24, 2026

    17th Global Pharmacovigilance & Clinical Trials Summit

    London, UK
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, Aland Islands
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands

    USFDA Approved Biosimilars Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in